[1] [1] YAMAGUCHI J, KINOSHITA K, IHARA S, et al. The clinical significance of low serum arachidonic acid in sepsis patients with hypoalbuminemia[J]. Intern Med, 2018, 57(13): 1833-1840.

[3] [3] PIOTTI A, NOVELLI D, MEESSEN J M T A, et al. Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS[J]. Crit Care, 2021, 25(1): 113.

[4] [4] TENG Y H, AQUINO R S, PARK P W. Molecular functions of syndecan-1 in disease[J]. Matrix Biol, 2012, 31(1): 3-16.

[5] [5] HAYASHIDA K, CHEN Y, BARTLETT A H, et al. Syndecan-1 is anin vivosuppressor of Gram-positive toxic shock[J]. J Biol Chem, 2008, 283(29): 19895-19903.

[6] [6] BODE L, SALVESTRINI C, PARK P W, et al. Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function[J]. J Clin Invest, 2008, 118(1): 229-238.

[7] [7] SALLISALMI M, TENHUNEN J, YANG R, et al. Vascular adhesion protein-1 and syndecan-1 in septic shock[J]. Acta Anaesthesiol Scand, 2012, 56(3): 316-322.

[8] [8] JOHANSEN M E, JOHANSSON P I, OSTROWSKI S R, et al. Profound endothelial damage predicts impending organ failure and death in sepsis[J]. Semin Thromb Hemost, 2015, 41(1): 16-25.

[9] [9] YINI S, HENG Z, XIN A, et al. Effect of unfractionated heparin on endothelial glycocalyx in a septic shock model[J]. Acta Anaesthesiol Scand, 2015, 59(2): 160-169.

[10] [10] LI X, MA X C. The role of heparin in sepsis: much more than just an anticoagulant[J]. Br J Haematol, 2017, 179(3): 389-398.

[11] [11] WANG X F, LI A M, LI J, et al. Low molecular weight heparin relieves experimental colitis in mice by downregulating IL-1 and inhibiting syndecan-1 shedding in the intestinal mucosa[J]. PLoS One, 2013, 8(7): e66397.

[14] [14] MURCH S H, PHILLIPS D, WALKER-SMITH J A, et al. Congenital enterocyte heparan sulphate deficiency with massive albumin loss, secretory diarrhoea, and malnutrition[J]. Lancet, 1996, 347(9011): 1299-1301.

[15] [15] ZHANG Y, WANG Z Q, LIU J, et al. Suppressing syndecan-1 shedding ameliorates intestinal epithelial inflammation through inhibiting NF-B pathway and TNF-[J]. Gastroenterol Res Pract, 2016, 2016: 6421351.

[18] [18] BECKER B F, JACOB M, LEIPERT S, et al. Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases[J]. Br J Clin Pharmacol, 2015, 80(3): 389-402.

[19] [19] VAN GOLEN R F, VAN GULIK T M, HEGER M. Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury[J]. Free Radic Biol Med, 2012, 52(8): 1382-1402.

[20] [20] STEPPAN J, HOFER S, FUNKE B, et al. Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix[J]. J Surg Res, 2011, 165(1): 136-141.

[21] [21] OSTROWSKI S R, GANI S, PEDERSEN C, et al. Sympathoadrenal activation and endothelial damage in patients with varying degrees of acute infectious disease: an observational study[J]. J Crit Care, 2015, 30(1): 90-96.

[22] [22] SMART L, BOSIO E, MACDONALD S P J, et al. Glycocalyx biomarker syndecan-1 is a stronger predictor of respiratory failure in patients with sepsis due to pneumonia, compared to endocan[J]. J Crit Care, 2018, 47: 93-98.

[23] [23] DAY R M, MITCHELL T J, KNIGHT S C, et al. Regulation of epithelial syndecan-1 expression by inflammatory cytokines[J]. Cytokine, 2003, 21(5): 224-233.

[25] [25] WIESINGER A, PETERS W, CHAPPELL D, et al. Nanomechanics of the endothelial glycocalyx in experimental sepsis[J]. PLoS One, 2013, 8(11): e80905.

[26] [26] YAMAKAWA K, UMEMURA Y, HAYAKAWA M, et al. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan[J]. Crit Care, 2016, 20(1): 229.

[27] [27] LI X, ZHENG Z, LI X, et al. Unfractionated heparin inhibits lipopolysaccharide-induced inflammatory response through blocking p38 MAPK and NF-B activation on endothelial cell[J]. Cytokine, 2012, 60(1): 114-121.

[28] [28] LI X, ZHENG Z, MAO Y R, et al. Unfractionated heparin promotes LPS-induced endothelial barrier dysfunction: a preliminary study on the roles of angiopoietin/Tie2 axis[J]. Thromb Res, 2012, 129(5): e223-8.

[29] [29] LI X, LI Z L, ZHENG Z, et al. Unfractionated heparin ameliorates lipopolysaccharide-induced lung inflammation by downregulating nuclear factor-B signaling pathway[J]. Inflammation, 2013, 36(6): 1201-1208.

[30] [30] ZARYCHANSKI R, DOUCETTE S, FERGUSSON D, et al. Early intravenous unfractionated heparin and mortality in septic shock[J]. Crit Care Med, 2008, 36(11): 2973-2979.

[31] [31] LI X, ZHAO E F, LI L, et al. Unfractionated heparin modulates lipopolysaccharide-induced cytokine production by different signaling pathways in THP-1 cells[J]. J Interferon Cytokine Res, 2018, 38(7): 283-289.

[32] [32] CHEN S, ZHANG X J, SUN Y N, et al. Unfractionated heparin attenuates intestinal injury in mouse model of sepsis by inhibiting heparanase[J]. Int J Clin Exp Pathol, 2015, 8(5): 4903-4912.

[33] [33] FU S F, YU S H, ZHAO Y L, et al. Unfractionated heparin attenuated histone-induced pulmonary syndecan-1 degradation in mice: a preliminary study on the roles of heparinase pathway[J]. Inflammation, 2022, 45(2): 712-724.